• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥西卓司他成功治疗青少年异位促肾上腺皮质激素分泌所致库欣综合征

Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat.

作者信息

Blew Kathryn, Van Mater David, Page Laura

机构信息

Pediatric Endocrinology & Diabetes, Department of Pediatrics, Duke University, Durham, NC 27705, USA.

Pediatric Hematology-Oncology, Department of Pediatrics, Duke University, Durham, NC 27710, USA.

出版信息

JCEM Case Rep. 2023 Aug 17;1(4):luad101. doi: 10.1210/jcemcr/luad101. eCollection 2023 Jul.

DOI:10.1210/jcemcr/luad101
PMID:37908982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10580455/
Abstract

A previously healthy 11-year-old male was found to have a mass in the pancreatic head after several months of abdominal pain and jaundice. Pathology was consistent with a World Health Organization grade 2 pancreatic neuroendocrine tumor. He developed refractory hypertension and was found to have Cushing syndrome from ectopic ACTH secretion, with oligometastatic liver disease. He underwent surgical resection of the pancreatic tumor and metastases. Postoperatively, his Cushing syndrome resolved, but it reemerged 1 year later in the setting of disease recurrence. He was not a candidate for bilateral adrenalectomy. Ketoconazole therapy was inadequate and he was started on metyrapone, lanreotide, cabergoline, and spironolactone. Although this regimen was well-tolerated, his Cushing syndrome recurred 4 months later as his metastatic disease burden increased. Osilodrostat was begun and the dose was gradually increased in response to his uncontrolled Cushing syndrome. Osilodrostat resulted in rapid improvement and eventual normalization of his urinary free cortisol at a dose of 18 mg twice daily. He had no adverse effects. This rare case highlights the successful off-label use of osilodrostat, a medication intended for refractory Cushing disease in adult patients, in a pediatric patient with Cushing syndrome caused by ectopic ACTH secretion.

摘要

一名此前健康的11岁男性,在经历数月腹痛和黄疸后,被发现胰头有一肿块。病理结果符合世界卫生组织2级胰腺神经内分泌肿瘤。他出现了难治性高血压,且因异位促肾上腺皮质激素分泌导致库欣综合征,并伴有寡转移肝病。他接受了胰腺肿瘤及转移灶的手术切除。术后,他的库欣综合征得到缓解,但1年后疾病复发时又再次出现。他不适合进行双侧肾上腺切除术。酮康唑治疗效果不佳,于是开始使用甲吡酮、兰瑞肽、卡麦角林和螺内酯。尽管该治疗方案耐受性良好,但随着他转移疾病负担的增加,4个月后库欣综合征再次复发。开始使用奥西卓他,根据其未得到控制的库欣综合征情况逐渐增加剂量。奥西卓他每日两次,每次18毫克的剂量使他的尿游离皮质醇迅速改善并最终恢复正常。他没有出现不良反应。这个罕见病例凸显了奥西卓他成功的超说明书用药情况,该药物原本用于成年患者的难治性库欣病,而在此用于一名因异位促肾上腺皮质激素分泌导致库欣综合征的儿科患者。

相似文献

1
Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat.奥西卓司他成功治疗青少年异位促肾上腺皮质激素分泌所致库欣综合征
JCEM Case Rep. 2023 Aug 17;1(4):luad101. doi: 10.1210/jcemcr/luad101. eCollection 2023 Jul.
2
A Case of an Ectopic ACTH-Producing Tumor With Adrenal Shrinkage During Osilodrostat Administration.一例在使用奥西卓司他期间出现肾上腺萎缩的异位促肾上腺皮质激素分泌肿瘤病例。
JCEM Case Rep. 2024 Jan 27;2(2):luae008. doi: 10.1210/jcemcr/luae008. eCollection 2024 Feb.
3
Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer.异位分泌促肾上腺皮质激素的不常见原因:归因于小细胞前列腺癌的库欣综合征。
Endocr Pract. 2010 Mar-Apr;16(2):249-54. doi: 10.4158/EP09243.CR.
4
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.奥昔司他特是一种潜在的新型类固醇生成抑制剂,可用于治疗库欣综合征:一项体外研究。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3437-3449. doi: 10.1210/jc.2019-00217.
5
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.奥西罗度肽治疗副肿瘤性库欣综合征的疗效和安全性:法国真实世界多中心研究。
J Clin Endocrinol Metab. 2023 May 17;108(6):1475-1487. doi: 10.1210/clinem/dgac691.
6
Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.蝶窦异位促肾上腺皮质激素分泌垂体腺瘤:经鼻内镜切除术病例报告及文献系统综述
Neurosurg Focus. 2015 Feb;38(2):E10. doi: 10.3171/2014.10.FOCUS14685.
7
Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.促肾上腺皮质激素分泌型神经内分泌肿瘤的治疗和双侧肾上腺切除术在外周性库欣综合征中的作用。
Surgery. 2022 Aug;172(2):559-566. doi: 10.1016/j.surg.2022.03.014. Epub 2022 Apr 16.
8
Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.胸腺神经内分泌癌切除 6 年后反复发作的急性发作库欣综合征:从异位 ACTH 到 CRH。
Endocr Pathol. 2013 Mar;24(1):25-9. doi: 10.1007/s12022-012-9228-5.
9
ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.异位库欣综合征:来自印度南部一家三级医疗中心的10年经验
Endocr Pract. 2017 Aug;23(8):907-914. doi: 10.4158/EP161677.OR. Epub 2017 Jun 14.
10
Adrenal Cushing's Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy.术前使用奥西卓司他和肾上腺切除术治疗肾上腺库欣综合征。
AACE Clin Case Rep. 2022 Oct 10;8(6):267-270. doi: 10.1016/j.aace.2022.10.001. eCollection 2022 Nov-Dec.

引用本文的文献

1
Successful Treatment of Severe Ectopic ACTH-Dependent Cushing Syndrome Complicated by Hypocalcemia With Osilodrostat.奥西卓司他成功治疗重度异位促肾上腺皮质激素(ACTH)依赖性库欣综合征并伴有低钙血症
JCEM Case Rep. 2025 Jan 20;3(2):luae255. doi: 10.1210/jcemcr/luae255. eCollection 2025 Feb.
2
Medical Treatment of Cushing's Syndrome.库欣综合征的医学治疗
Endocrinol Metab (Seoul). 2025 Feb;40(1):26-38. doi: 10.3803/EnM.2024.501. Epub 2025 Jan 13.
3
Adrenal Cushing's syndrome in children.儿童库欣综合征。

本文引用的文献

1
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.奥西罗度肽治疗副肿瘤性库欣综合征的疗效和安全性:法国真实世界多中心研究。
J Clin Endocrinol Metab. 2023 May 17;108(6):1475-1487. doi: 10.1210/clinem/dgac691.
2
Osilodrostat for Cushing Disease and Its Role in Pediatrics.奥昔拉定治疗库欣病及其在儿科中的作用。
Horm Res Paediatr. 2023;96(6):573-580. doi: 10.1159/000522054. Epub 2022 Jan 19.
3
Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease.
Front Endocrinol (Lausanne). 2023 Dec 12;14:1329082. doi: 10.3389/fendo.2023.1329082. eCollection 2023.
奥昔拉定:最近临床研究综述及在库欣病治疗中应用的实用建议。
Endocr Pract. 2021 Sep;27(9):956-965. doi: 10.1016/j.eprac.2021.06.012. Epub 2021 Aug 10.
4
MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion.内分泌疾病管理:异位 ACTH 分泌所致库欣综合征:专家实践意见。
Eur J Endocrinol. 2020 Apr;182(4):R29-R58. doi: 10.1530/EJE-19-0877.
5
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients.库欣综合征的诊断时间:基于 5367 例患者的荟萃分析。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz136.
6
Cushing's Syndrome in Pediatrics: An Update.儿童库欣综合征:最新进展。
Endocrinol Metab Clin North Am. 2018 Jun;47(2):451-462. doi: 10.1016/j.ecl.2018.02.008.
7
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.库欣综合征的治疗:美国内分泌学会临床实践指南
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.
8
Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it.儿童和青少年中导致库欣综合征的异位促肾上腺皮质激素和促肾上腺皮质激素释放激素共同分泌肿瘤:诊断困境及解决方法
J Clin Endocrinol Metab. 2015 Jan;100(1):141-8. doi: 10.1210/jc.2014-2945.